Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK
NIDDK is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19). NIDDK is particularly interested in projects focusing on the direct action of the virus on kidney, gastrointestinal tract function, and the endocrine/metabolic system, and the collection of biosamples that will inform the understanding of renal, gastrointestinal, and endocrine/metabolic sequelae of viral infection. Pilot clinical studies (observational and interventional) that support the understanding or treatment of COVID-19-related diseases within the mission of the NIDDK are also of interest. NIDDK will only consider applications that propose projects that may lead to rapid translation and impact in the COVID-19 emergency to be responsive to this NOSI.
Please submit applications for this initiative using the following funding opportunity announcement (FOA) below:
PA-18-935: Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)
The application due date is June 01, 2020.
More information about the COVID-19 NIDDK NOSI is available at: https://grants.nih.gov/grants/guide/notice-files/NOT-DK-20-018.html.
Please direct all inquiries to the appropriate NIDDK staff contact below:
Ivonne H. Schulman
Division of Kidney, Urologic and Hematologic Diseases (DKUH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: (301) 385-5744
Email: ivonne.schulman@nih.gov
Christine Lee
Division of Diabetes, Endocrinology and Metabolic Diseases (DEM)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: (301) 594-8806
Email: christine.lee2@nih.gov
Peter Perrin
|Division of Digestive Diseases and Nutrition (DDN)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: (301) 451-3759